Skip to main content

Table 3 Patient Characteristics

From: Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response

 

All

Primary Stage III & IV

 

Patients

%

Patients

%

Number of patients

104

100

77

100

Stage

    

I

5

4.8 %

  

II

2

1.9 %

  

III

67

64.4 %

67

87.0 %

IV

10

9.6 %

10

13.0 %

Recurrent

20

19.2 %

  

Debulking

    

No

5

4.8 %

3

3.9 %

yes optimal

79

76.0 %

58

75.3 %

yes suboptimal

20

19.2 %

16

20.8 %

Size of residual

    

0

56

56.6 %

39

52.7 %

<1 cm

18

18.2 %

15

20.3 %

>1 cm

25

25.3 %

20

27.0 %

Lines of therapy before MiCK

    

0

87

83.7 %

77

100 %

1

4

3.8 %

  

2

3

2.9 %

  

3

10

9.6 %

  

Preoperative CA125

    

mean

1714.5

 

2147.6

 

median

384.5

 

510.5

 

range

4 - 26,728

 

4 - 26,728

 

missing

13

 

11

 

Age

    

mean

59.4

 

59.7

 

median

60

 

60

 

range

35 - 86

 

37 - 86